Accumulating evidence demonstrates that the AKT/mTOR signalling pathway can modulate neuroprotective activation following cerebral ischemia-reperfusion (I/R) (Zheng et al., 2017). The gene discussed is MTOR; the disease is Cerebral ischemia.